Cargando…

Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients

Introduction: Preventing side effects is important to ensure optimal psychopharmacotherapy and therapeutic adherence among psychiatric patients. Obtaining the pharmacogenetic profile of CYP2C19 and CYP2D6 can play an important role in this. When the genotype-predicted phenotype shifts because of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	den Uil, Manon G., Hut, Hannelotte W., Wagelaar, Kay R., Abdullah-Koolmees, Heshu, Cahn, Wiepke, Wilting, Ingeborg, Deneer, Vera H. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486269/ https://www.ncbi.nlm.nih.gov/pubmed/37693320 http://dx.doi.org/10.3389/fgene.2023.1249164

Ejemplares similares

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
por: Abdullah-Koolmees, Heshu, et al.
Publicado: (2021)

The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes
por: Nawzad, Sina, et al.
Publicado: (2022)

Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness
por: Koomen, Lisanne, et al.
Publicado: (2023)

Use of Pharmacogenetic Drugs by the Dutch Population
por: Alshabeeb, Mohammad A., et al.
Publicado: (2019)

Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study
por: Scherf-Clavel, Maike, et al.
Publicado: (2023)

Dasatinib-induced nephrotic syndrome: a case of phenoconversion?
por: Mandac Rogulj, Inga, et al.
Publicado: (2019)

Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion
por: Gharaee-Kermani, Mehrnaz, et al.
Publicado: (2016)

CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis
por: Gharaee-Kermani, Mehrnaz, et al.
Publicado: (2012)

The role of club cell phenoconversion and migration in idiopathic pulmonary fibrosis
por: Fukumoto, Jutaro, et al.
Publicado: (2016)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
por: Klomp, Sylvia D., et al.
Publicado: (2020)

Cardiosomal microRNAs Are Essential in Post-Infarction Myofibroblast Phenoconversion
por: Morelli, Marco B., et al.
Publicado: (2019)

Sleep Disturbances and Phenoconversion in Patients with REM Sleep Behavior Disorder
por: Jo, Hyunjin, et al.
Publicado: (2021)

Pharmacogenetic CYP2D6 variability, phenoconversion and treatment outcomes: A Danish population-based cohort study in 6,798 individuals initiating atomoxetine treatment
por: Ishtiak-Ahmed, K., et al.
Publicado: (2022)

From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics
por: Wilffert, Bob, et al.
Publicado: (2010)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)

Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009)

The impact of CYP2C19 genotype on phenoconversion by concomitant medication
por: de Jong, Laura M., et al.
Publicado: (2023)

Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort
por: Orso, Beatrice, et al.
Publicado: (2023)

Bariatric surgery in patients with psychiatric comorbidity: Significant weight loss and improvement of physical quality of life
por: Vermeer, Karlijn J., et al.
Publicado: (2020)

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
por: Macciardi, Fabio, et al.
Publicado: (2022)

Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder
por: Ganapathy S., Ranjani, et al.
Publicado: (2022)

Pharmacogenetics and Psychiatric Care: A Review and Commentary
por: Butler, Merlin G.
Publicado: (2018)

Encountering Pharmacogenetic Test Results in the Psychiatric Clinic
por: Bousman, Chad A, et al.
Publicado: (2021)

Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder
por: Zolfaghari, Sheida, et al.
Publicado: (2022)

Revealing the impact of psychiatric comorbidities on treatment outcome in early psychosis using counterfactual model explanation
por: van Dee, Violet, et al.
Publicado: (2023)

Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers
por: Chen, Qin, et al.
Publicado: (2019)

Differential subcellular expression of (P525L)FUS as a putative biomarker for ALS phenoconversion
por: Caputo, Maria, et al.
Publicado: (2020)

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”
por: Puligheddu, Monica, et al.
Publicado: (2022)

Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder
por: Mattioli, Pietro, et al.
Publicado: (2022)

Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
por: Ivashchenko, D., et al.
Publicado: (2022)

Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015)

Tamoxifen side effects: pharmacogenetic and clinical approach in Mexican mestizos
por: Rangel-Méndez, Jorge-Aarón, et al.
Publicado: (2019)

Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder
por: Yoon, Eun Jin, et al.
Publicado: (2022)

Correction to: Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”
por: Puligheddu, Monica, et al.
Publicado: (2022)

Cardiac 18F-Dopamine Positron Emission Tomography Predicts the Type of Phenoconversion of Pure Autonomic Failure
por: Lenka, Abhishek, et al.
Publicado: (2023)

Usefulness of Pharmacogenetic Analysis in Psychiatric Clinical Practice: A Case Report
por: Franco-Martin, Manuel A., et al.
Publicado: (2018)

Pharmacogenetic Testing in an Academic Psychiatric Clinic: A Retrospective Chart Review
por: Brown, Lisa, et al.
Publicado: (2021)

Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
por: Gemmati, Donato, et al.
Publicado: (2020)

Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics
por: Voskuil, Michiel Dirk, et al.
Publicado: (2019)

Use of illicit substances and violent behaviour in psychotic disorders: two nationwide case-control studies and meta-analyses
por: Lamsma, Jelle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uj6fpuvnb9s2lp4j909geg427g